Polymorphisms in the interleukin 6 and transforming growth factor β1 gene and risk of dementia: The Rotterdam Study

https://doi.org/10.1016/j.neulet.2006.03.050Get rights and content

Abstract

Inflammatory mechanisms are involved in the pathogenesis of dementia. Inflammatory cytokines, including interleukin-6 (IL-6) and transforming growth factor β1 (TGFβ1), have been found in association with Alzheimer pathology and there is evidence for direct involvement of these cytokines in formation of amyloid plaques. Polymorphisms in genes encoding for IL-6 and TGFβ1 are associated with plasma levels of IL-6 and TGFβ1. Studies examining the association between polymorphisms in these genes and dementia yielded conflicting results. The purpose of this study was to examine the association between genetic variance in IL-6 and TGFβ1 and risk of dementia. We examined this association in the Rotterdam Study, a prospective population-based cohort study in the elderly. Polymorphisms in the IL-6 (−174G>C) and TGFβ1 gene (−800G>A, −509C>T, +10T>C, +25G>C and 263C>T) were genotyped and haplotypes of the TGFβ1 gene were constructed. In a random subset IL-6 plasma levels were measured. During follow-up (mean 9.2 years), 743 dementia cases were identified. We estimated the association between individual polymorphisms and haplotypes with dementia with Cox’ proportional hazard models. No association was found between the −174G>C polymorphism in the IL-6 gene and risk of dementia. No association was found between polymorphisms and constructed haplotypes in the TGFβ1 gene and risk of dementia or Alzheimer's disease. No association was found between IL-6 genotype and IL-6 plasma levels in the random subset. Associations did not differ across APOE genotypes. Our findings do not suggest involvement of genetic variance in IL-6 and TGFβ1 in the development of dementia.

Section snippets

Acknowledgements

This study was supported by the Netherlands Organization for Scientific Research (NWO grant 904-61093) and by the European Commission (grant QLK6-CT-2002 02629, “GENOMOS”).

The Rotterdam Study is supported by the Erasmus Medical Center and Erasmus University Rotterdam, The Netherlands Organization for Scientific Research (NWO), the Netherlands Organization for Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture

References (37)

  • B. Yucesoy et al.

    Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study

    Neurobiol. Aging

    (2006)
  • Y. Zhang et al.

    Interleukin-6 promoter polymorphism: risk and pathology of Alzheimer's disease

    Neurosci. Lett.

    (2004)
  • American Psychiatry Associtaion. Diagnostic and Statistical Manual of Mental Disorders,...
  • L. Araria-Goumidi et al.

    Association study of three polymorphisms of TGF-beta1 gene with Alzheimer's disease

    J. Neurol. Neurosurg. Psychiatry

    (2002)
  • J.J. Barendregt et al.

    Consistency of epidemiologic estimates

    Eur. J. Epidemiol.

    (2005)
  • I.L. Campbell et al.

    Transgenic models to assess the pathogenic actions of cytokines in the central nervous system

    Mol. Psychiatry

    (1997)
  • C.C. Chao et al.

    Serum cytokine levels in patients with Alzheimer's disease

    Clin. Diagn. Lab. Immunol.

    (1994)
  • J.R. Copeland et al.

    A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. I. Development and reliability

    Psychol. Med.

    (1976)
  • Cited by (41)

    • The impact of metabotropic glutamate receptors into active neurodegenerative processes: A “dark side” in the development of new symptomatic treatments for neurologic and psychiatric disorders

      2017, Neuropharmacology
      Citation Excerpt :

      Expression of neuronal type-II TGF-β receptors is reduced in the AD brain, and dysfunction of TGF-β signaling causes AD pathology and neurodegeneration in mice (Das and Golde, 2006; Tesseur et al., 2006; reviewed by Caraci et al., 2012). The link between TGF-β and AD is strengthened by the association between AD and TGF-β1 gene polymorphism (Luedecking et al., 2000; Dickson et al., 2005; Arosio et al., 2007; Caraci et al., 2012; Bosco et al., 2013; but see also Araria-Goumidi et al., 2002; Rodríguez-Rodríguez et al., 2007; van Oijen et al., 2006; and Chang et al., 2013 for lack of association). mGlu3 receptor PAMs might be promising candidates as disease-modifiers in the treatment of AD because they are expected to stimulate the production of TGF-β, rescue memory deficits, and induce neuroprotection (reviewed by Bruno et al., 2001).

    • Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis

      2016, Meta Gene
      Citation Excerpt :

      Three studies (Fontalba et al., 2009, Combarros et al., 2005 and Infante et al., 2004) provided deficient genotype data. Also, the genotype data presented by van Oijen et al.'s (2006) group may overlap with that of Combarros et al. 2010 (Rotterdam study). However, the Qi et al. meta-analysis included these four studies.

    • Genetic and environmental determinants of population variation in interleukin-6, its soluble receptor and C-reactive protein: Insights from identical and fraternal twins

      2015, Brain, Behavior, and Immunity
      Citation Excerpt :

      However, this general conclusion is often, and inappropriately, overgeneralized to all aspects of IL-6 synthesis and release. In the absence of inflammatory stimuli, SNPs have a weak or no association with baseline levels of IL-6 in the blood stream (Bagli et al., 2003; Bennermo et al., 2004; Brull et al., 2001; Burzotta et al., 2001; Herbert et al., 2006; Lieb et al., 2004; Nauck et al., 2002; Sen et al., 2011; Shah et al., 2013; van Oijen et al., 2006; Wernstedt et al., 2004). On the other hand, SNPs affecting sIL-6r production appear to be more consistently associated with its levels in systemic circulation (Galicia et al., 2004; Rafiq et al., 2007; Sasayama et al., 2012; van Dongen et al., 2014).

    View all citing articles on Scopus
    View full text